Search
Forte Biosciences Inc
FBRXAdd to Watchlist
21.030USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
272.30MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-26The current earnings forecast score of Forte Biosciences Inc is 8.40, ranking 126 out of 387 in the Biotechnology & Medical Research industry. The average price target is 61.00, with a high of 75.00 and a low of 19.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
63.750
Target Price
+240.73%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Forte Biosciences Inc
FBRX
5
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Forte Biosciences Inc's price target?
Analysts forecast that Forte Biosciences Inc's price target is USD 61.00, with the highest forecast at USD 75.00 and the lowest forecast at USD 19.00.
How have Forte Biosciences IncFBRX's recent earnings per share performed?
The market expectation was USD -1.24, while Forte Biosciences IncFBRX's earnings per share (EPS) for the previous quarter was USD -1.39. EPS for the next quarter is expected at USD -1.03.
What is the analyst rating for Forte Biosciences Inc?
Based on the ratings of Forte Biosciences Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
